For the year ending 2025-12-31, LIMN has $512,795 in assets. $10,327,485 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 337,655 | |||
| Prepaid and other current assets | 162,919 | |||
| Total current assets | 500,574 | |||
| Property and equipment, net | 12,221 | |||
| Total non-current assets | 12,221 | |||
| Total assets | 512,795 | |||
| Accounts payable and accrued expenses | 582,234 | |||
| Accrued interest, related parties | 203,921 | |||
| Due to related parties | 209,586 | |||
| Short-term debt, related parties | 1,442,500 | |||
| Deferred underwriting fee payable | 500,000 | |||
| Settlement payable | 7,360,000 | |||
| Total current liabilities | 10,298,241 | |||
| Warrant liability | 29,244 | |||
| Total liabilities | 10,327,485 | |||
| Common stock, 0.0001 par value 500,000,000 shares authorized 27,064,633 and 17,500,000 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 2,706 | |||
| Additional paid-in capital | 29,054,337 | |||
| Accumulated deficit | -38,871,733 | |||
| Total stockholders' deficit | -9,814,690 | |||
| Total liabilities and stockholders' deficit | 512,795 | |||
Liminatus Pharma, Inc. (LIMN)
Liminatus Pharma, Inc. (LIMN)